This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Galecto Biotech Ab. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Balaram Mukhopadhyay: Innovator in Galectin Inhibition
Introduction
Balaram Mukhopadhyay is a notable inventor based in Kolkata, West Bengal, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit galectins. His work is crucial for advancing treatments for various disorders related to galectin binding.
Latest Patents
Balaram Mukhopadhyay holds a patent for "Galectoside inhibitors of galectins." This invention relates to novel compounds derived from readily accessible 3-O-propargyl-D-galactopyranoside derivatives. These compounds serve as galectin inhibitors and are intended for use as medicaments for treating disorders associated with galectin binding in mammals, specifically targeting galectin-3. The compounds are defined by a specific general formula.
Career Highlights
Balaram Mukhopadhyay is currently associated with Galecto Biotech AB, where he continues to innovate in the field of galectin research. His work has the potential to impact therapeutic approaches significantly.
Collaborations
He collaborates with esteemed colleagues such as Ulf Nilsson and Hakon Leffler, contributing to a dynamic research environment focused on galectin inhibitors.
Conclusion
Balaram Mukhopadhyay's innovative work in galectin inhibition showcases his commitment to advancing medical science. His contributions are paving the way for new treatments that could benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile